Literature DB >> 15713390

The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists.

Pauline C Ting1, Joe F Lee, Jie Wu, Shelby P Umland, Robert Aslanian, Jianhua Cao, Youhao Dong, Charles G Garlisi, Eric J Gilbert, Ying Huang, James Jakway, Joseph Kelly, Zhidan Liu, Stuart McCombie, Himanshu Shah, Fang Tian, Yuntao Wan, Neng-Yang Shih.   

Abstract

Bipiperidine amide 1 has been identified as a CC chemokine receptor 3 (CCR3) antagonist. Optimization of its structure-activity relationship has resulted in the identification of cis (R,R)-4-[(3,4-dichlorophenyl)methyl]-3-hydroxymethyl-1'(6-quinolinylcarbonyl)-1,4'-bipiperidine 14n, which exhibits potent receptor affinity and inhibition of both calcium flux and eosinophil chemotaxis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713390     DOI: 10.1016/j.bmcl.2005.01.016

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation.

Authors:  Emma L Wise; Cécile Duchesnes; Paula C A da Fonseca; Rodger A Allen; Timothy J Williams; James E Pease
Journal:  J Biol Chem       Date:  2007-07-16       Impact factor: 5.157

2.  Total Synthesis of (±)-Paroxetine by Diastereoconvergent Cobalt-Catalysed Arylation.

Authors:  Carole F Despiau; Andrew P Dominey; David C Harrowven; Bruno Linclau
Journal:  European J Org Chem       Date:  2014-05-27

3.  Highly Selective Synthesis of 6-Glyoxylamidoquinoline Derivatives via Palladium-Catalyzed Aminocarbonylation.

Authors:  Sami Chniti; László Kollár; Attila Bényei; Attila Takács
Journal:  Molecules       Date:  2021-12-21       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.